Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
FY2026 revenue €23.60bn; adjusted EBIT margin 16.2%.
Comparable revenue growth 4.0%; adjusted EBIT about €3.8bn. Net income not captured.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Nov 2025: Siemens AG decided to give up control of Siemens Healthineers, planning to spin off about 30% of the shares to its own shareholders and reduce its remaining ~67% stake to a financial investment over time, subject to approvals.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator actions involving Siemens Healthineers found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Sep 2026: Siemens began an FDA Class 2 recall of ACUSON Origin ultrasound systems (software 4.0) because a software issue could unintentionally activate an uncleared Color Doppler setting and cause the system to crash or freeze.
Contract delivery, go-lives, terminations and disputes.
No contract disputes, terminations or troubled implementations involving Siemens Healthineers found in HSH's search of the last 24 months.